Since 2018, there has been a dramatic upsurge in publications relating to the use of vitamin C in critically ill patients, particularly those suffering from sepsis [1]. This has primarily been in response to the well-publicized before-and-after study of Marik et al. [2], which indicated that intravenous administration of 6 g/day vitamin C (in combination with thiamine and hydrocortisone) could improve the outcomes of patients with sepsis, including decreasing mortality. Over the past year, seven meta-analyses assessing the effects of vitamin C administration in critically ill patients have been published, with four appearing in the past 4 months alone (see Table 1 summary). Table 1 A summary of recent meta-analysis of vitamin C administration in critical care patients Full size table

The most recently published and largest meta-analysis included 44 randomized controlled trials (16 intensive care and 28 cardiac surgery) [9]. Although meta-analyses that include a larger number of studies have increased power, they run the risk of comparing disparate studies. This is particularly the case with vitamin C studies whereby the dose (milligrams vs grams), rout of administration (oral vs intravenous), duration (hours vs days), and disease (e.g., sepsis vs cardiac surgery) can have a large impact on outcomes [10, 11]. Therefore, appropriate subgroup analyses should be carried out, although this is currently challenging due to the low number of comparable studies.

All but one of the current meta-analyses have focused on mortality as a primary outcome, despite many of the included trials having relatively low numbers of patients. In most cases, no effect of intervention was observed on mortality, except in specific subgroup analyses (e.g., sepsis and higher dose intravenous vitamin C). However, there have been few of these studies published to date, and even fewer of high methodological quality [6]. Other commonly assessed outcomes included ICU and hospital length of stay, duration of vasopressor support and mechanical ventilation, and acute kidney injury. Some of the meta-analyses showed decreases in several of these secondary outcomes, while others showed no effect, depending on the selection criteria used for study inclusion (Table 1).

There are currently over a dozen randomized controlled trials registered on clinicaltrials.gov that are assessing the effects of vitamin C administration in critically ill patients, particularly those with sepsis. One would hope that in the short term, no more meta-analyses appear every time another small study is published, but instead wait until some of the larger trials (such as VICTAS and LOVIT) have been completed. Otherwise, there may end up with more meta-analyses than published trials.

Availability of data and materials NA

References 1. Li J. Evidence is stronger than you think: a meta-analysis of vitamin C use in patients with sepsis. Crit Care. 2018;22(1):258. 2. Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017;151(6):1229–38. 3. Putzu A, Daems AM, Lopez-Delgado JC, Giordano VF, Landoni G. The effect of vitamin C on clinical outcome in critically ill patients: A systematic review with meta-analysis of randomized controlled trials. Crit Care Med. 2019;47(6):774–83. 4. Wang Y, Lin H, Lin BW, Lin JD. Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis. Annals of intensive care. 2019;9(1):58. 5. Hemila H, Chalker E. Vitamin C can shorten the length of stay in the ICU: A meta-analysis. Nutrients. 2019;11(4). 6. Langlois PL, Manzanares W, Adhikari NKJ, Lamontagne F, Stoppe C, Hill A, et al. Vitamin C supplementation in the critically ill: A systematic review and meta-analysis. JPEN Parenter Enteral Nutr. 2019. 7. Zhang M, Jativa DF. Vitamin C supplementation in the critically ill: A systematic review and meta-analysis. SAGE open medicine.2018;6:2050312118807615. 8. Lin J, Li H, Wen Y, Zhang M. Adjuvant administration of vitamin C improves mortality of patients with sepsis and septic shock: A systems review and meta-analysis. Open J Intern Med 2018;8:146–59. 9. Hooper MH, Hager DN. Understanding vitamin C in critical illness: a focus on dose, route, and disease. Crit Care Med. 2019;47(6):867–9. 10. Carr AC. Duration of intravenous vitamin C therapy is a critical consideration. Crit Care Resuscitation. 2019;In press. 11. Carr AC. Vitamin C in pneumonia and sepsis. In: Vissers M, Chen Q, editors. Oxidative Stress and Disease. Boca Raton Taylor and Francis Group; 2019. In press. Download references

Acknowledgements NA

Funding AC is supported by a Health Research Council of New Zealand Sir Charles Hercus Health Research Fellowship.

Author information Affiliations Department of Pathology and Biomedical Science, University of Otago, P.O. Box 4345, Christchurch, 8140, New Zealand Anitra C. Carr Authors Anitra C. Carr View author publications You can also search for this author in PubMed Google Scholar Contributions AC wrote the letter. The author read and approved the final manuscript. Corresponding author Correspondence to Anitra C. Carr.

Ethics declarations Ethics approval and consent to participate NA Consent for publication NA Competing interests The author declares that she has no competing interests.

Additional information Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This comment refers to the article available at https://doi.org/10.1186/s13054-018-2191-x.

Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Reprints and Permissions